This Week’s Life Science Headlines
- January 23, 2014
- Life Science Matters
- Class Action,Design Defect,FDA,Litigation,Medical Device,News,Nutritional Supplements,Pharmaceuticals,Preemption,Product Liability,Recalls,Regulatory,Supplements
- 0
Litigation
- Pharma Can Be Liable for Design Negligence: Pa. High Court (subscription required)
- Pfizer Escapes Whistleblower Suit Over Lipitor Marketing (subscription required)
- 23andMe Faces Suit Over Recently Banned DNA Tests (subscription required)
- Claims and Classes in Medical Monitoring Cases (subscription required)
- Boston Scientific Mesh Lawsuit to Move Forward After SOL Challenge
- Motion Filed to Centralize OxyElite Pro Lawsuits in MDL
- 6th Circuit Revives Mylan Wrongful Death Suit (subscription required)
- Jury Clears Abbott In Tainted Formula Injury Suit (subscription required)
- Ethicon Vaginal Mesh Plaintiffs Say Company Destroyed, Lost Key Files
- St. Jude Riata Lead Lawsuits Not Pre-empted, Federal Judge Rules
- Conference Set for Bayer Request on Mirena Statute of Limitations Motion
- Status Conferences in Tylenol Liver Failure Litigation Set Through 2014
- DePuy ASR Hip Lawsuit Given Expedited Trial Date in California
- Iovate Stuck in Bodybuilding Supplements False Ad Suit (subscription required)
Regulatory
- Proposed FDA Rule Could Bring Failure-To-Warn Liability (subscription required)
- FDA Overhauls ‘Dear Doctor’ Guidance on Drug Risks (subscription required)
- FDA Updates Mad Cow Disease Guidance for Medical Devices (subscription required)
- Draft Guidance – Medical Devices Containing Materials Derived from Animal Sources (Except for In Vitro Diagnostic Devices)
- FDA Warns Medical Food Co. Amid Continuing Crackdown (subscription required)
- Xarelto Risks Lead FDA Panel to Recommend Against Expansion
- CPSC Floats Changes to Product Info Disclosure Rules (subscription required)
- Some Wart Removers are Flammable
- Draft Guidance – Reporting of Computational Modeling Studies in Medical Device Submissions
Recalls
- Trufill n-BCA Liquid Embolic System by Codman Neuro: Recall
- Fresenius Recall Issued Over Problems with Dialysis Machines
- The Mentholatum Company Issues Voluntary Nationwide Recall of Rohto Eye Drops Made in Vietnam
- StemAlive 90 Capsules: Recall – Undeclared Milk
For a look at last week’s life science headlines, click here.
Tags: 23andMe lawsuit, boston scientific mesh lawsuit, CPSC changes, CPSC disclosure rules, DePuy ASR Hip, DePuy lawsuit, DNA tests, failure-to-warn liability, FDA, FDA "Dear Doctor" Guidance, FDA on mad cow disease, flammable wart removers, Fresenius recall, guidance on computational studies in medical device submissions, guidance on mad cow disease, guidance on medical devices with materials derived from animals, guidance on medical foods, hip lawsuit, iovate false ad suit, Lipitor, mad cow disease, medical food, medical monitoring cases, mentholatum recall, mirena statute of limitations, mylan wrongful death suit, oxyelite pro lawsuits, Pfizer, pfizer escapes whistleblower lawsuit, pharma can be liable for design negligence, rohto recall, st. jude riata, st. jude riata lawsuit, stemalive recall, tainted formula, Trufill n-BCA recall, Tylenol, tylenol lawsuit, tylenol liver failure, vaginal mesh, vaginal mesh lawsuit, wart removers, whistleblower, xarelto risksLeave a Comment Cancel reply
Categories
Recent Posts
- California Federal Court Permits Class Action Pet Food Lawsuit to Go Forward
- Medical Cannabis and the Potential for Criminal Charges
- Hydroponic Operations Fight for Organic Certification Amidst Disapproval from Traditionalists
- Litigation is the Pits – Claim Dismissed for Injuries Caused by Natural Food Substance
- FDA Resumes Inspections of Certain Foods during Government Shut Down
0 Comments
Be the first to leave a reply!